Summary
JPMorgan Chase & Co. (JPM) filed a Form 8-K on December 20, 2006, to report a specific exhibit. This filing is not a comprehensive financial update but rather an informational disclosure concerning a particular financial instrument. The key event relates to the filing of a Tax Opinion from Davis Polk & Wardwell. This Tax Opinion pertains to the "9.75% Reverse Exchangeable Notes due December 27, 2007, Linked to the Common Stock of Gilead Sciences, Inc." For investors, this highlights the company's engagement in structured products and derivatives, specifically a note whose return is tied to the performance of Gilead Sciences' stock. The inclusion of a tax opinion suggests the complexity and specific tax implications associated with these notes, which would be of interest to investors holding or considering such instruments.
Key Highlights
- 1JPM filed an 8-K on December 20, 2006.
- 2The filing's primary purpose is to disclose an exhibit.
- 3The exhibit is a Tax Opinion from Davis Polk & Wardwell.
- 4The Tax Opinion concerns 9.75% Reverse Exchangeable Notes.
- 5These notes mature on December 27, 2007.
- 6The notes are linked to the Common Stock of Gilead Sciences, Inc.